Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease

被引:12
|
作者
Alongi, Filippo [1 ,5 ]
Arcangeli, Stefano [2 ]
Triggiani, Luca [3 ]
Mazzola, Rosario [1 ]
di Monale e Bastia, Michela Buglione [3 ]
Fersino, Sergio [1 ]
Baiguini, Anna [3 ]
Jereczek-Fossa, Barbara Alicja [4 ]
Magrini, Stefano Maria [3 ]
机构
[1] Sacro Cuore Don Calabria Canc Care Ctr, Radiat Oncol, Negrar Verona, Italy
[2] San Camillo & Forlanini Hosp, Radiat Oncol, Rome, Italy
[3] Spedali Civili Brescia, Radiat Oncol, Brescia, Italy
[4] Univ Milan, European Inst Oncol, Radiat Oncol, Milan, Italy
[5] Univ Brescia, Brescia, Italy
关键词
Stereotactic radiotherapy; SABR; Renal cell carcinoma; Oligometastases; INITIAL CLINICAL-EXPERIENCE; DOSE-PER-FRACTION; BODY RADIOTHERAPY; SPINAL METASTASES; FOLLOW-UP; RADIOSURGERY; CANCER; IMMUNOTHERAPY; NEPHRECTOMY; KIDNEY;
D O I
10.1016/j.critrevonc.2017.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherapy was usually delivered with a palliative goal. Stereotactic ablative radiotherapy (SABR) allows the delivery of high doses on small treatment volumes in a safe and effective way, thus opening the doors to new applicationsof radiotherapy both in the treatment of the primary and oligometastasic disease. Aim of the current review is to explore the state of art of SABR in the therapeutic approach to RCC. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 50 条
  • [31] Immunotherapy and Radiation Therapy in Renal Cell Carcinoma
    Mollica, Veronica
    Santoni, Matteo
    Di Nunno, Vincenzo
    Cimadamore, Alessia
    Cheng, Liang
    Lopez-Beltran, Antonio
    Battelli, Nicola
    Montironi, Rodolfo
    Massari, Francesco
    CURRENT DRUG TARGETS, 2020, 21 (14) : 1463 - 1475
  • [32] Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
    Kim, Myungsoo
    Son, Seok Hyun
    Won, Yong Kyun
    Kay, Chul Seung
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [33] A review of stereotactic ablative radiotherapy for nonmetastatic renal cell carcinoma
    Zalay, Osbert
    Mehra, Prateek
    Pereira, Ian
    Malone, Julia
    Malone, Shawn
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [34] Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer
    Sutera, Philip
    Clump, David A.
    Kalash, Ronny
    D'Ambrosio, David
    Mihai, Alina
    Wang, Hong
    Petro, Daniel P.
    Burton, Steven A.
    Heron, Dwight E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (01): : 116 - 122
  • [35] Stereotactic Ablative Radiation Therapy for Primary Lung Tumors
    Heinzerling, John H.
    Kavanagh, Brian
    Timmerman, Robert D.
    CANCER JOURNAL, 2011, 17 (01) : 28 - 32
  • [36] Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases
    McDermott, Ronan L.
    Dunne, Emma M.
    Zhao, Yizhou
    Bergman, Alanah
    Liu, Mitchell C. C.
    Schellenberg, Devin
    Ma, Roy M. K.
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 120 - 128
  • [37] Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis
    Huang, Ryan S.
    Chow, Ronald
    Chopade, Pradnya
    Mihalache, Andrew
    Hasan, Asad
    Boldt, Gabriel
    Glicksman, Rachel
    Simone II, Charles B.
    Lock, Michael
    Raman, Srinivas
    RADIOTHERAPY AND ONCOLOGY, 2024, 194
  • [38] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
    Cem Onal
    Pervin Hurmuz
    Ozan Cem Guler
    Guler Yavas
    Burak Tilki
    Ezgi Oymak
    Cagdas Yavas
    Gokhan Ozyigit
    Clinical and Translational Oncology, 2022, 24 : 1533 - 1541
  • [39] Stereotactic Ablative Radiation for Systemic Therapy-na?ve Oligometastatic Kidney Cancer
    Hannan, Raquibul
    Christensen, Michael
    Christie, Alana
    Garant, Aurelie
    Pedrosa, Ivan
    Robles, Liliana
    Mannala, Samantha
    Wang, Chiachien
    Hammers, Hans
    Arafat, Waddah
    Courtney, Kevin
    Bowman, Isaac A.
    Sher, David
    Ahn, Chul
    Cole, Suzanne
    Choy, Hak
    Timmerman, Robert
    Brugarolas, James
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 695 - 703
  • [40] Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?
    Chapman, E. R.
    Correa, R. J. M.
    Palma, D. A.
    Van As, N.
    CLINICAL ONCOLOGY, 2022, 34 (05) : 318 - 324